Cite
HARVARD Citation
Morand, E. et al. (2022). Efficacy of anifrolumab across organ domains in patients with moderate-to-severe systemic lupus erythematosus: a post-hoc analysis of pooled data from the TULIP-1 and TULIP-2 trials. Lancet. pp. e282-e292. [Online].